Dec 14, 2020 | Motryx, News
Read Original Article
Simple and reliable validation of Pneumatic Tube Systems for blood sample integrity monitoring
Halifax, Canada, December 2020 – Motryx, provider of blood transport validation and verification services, today announced a partnership with Aerocom, a global leader in Pneumatic Tube Systems, for the joint provision of VitalQC – a quality assurance tool to validate pneumatic tube installations for safe and effective transport of blood samples with minimal impacts on integrity and diagnostics.
The efficiency of pneumatic systems has made them standard in most large hospitals worldwide; however, they must be confirmed as safe for the transport of blood samples from patient to lab. Under this new agreement, Aerocom will use Motryx’s VitalQC to monitor and continue to innovate on their >2000 hospital installations and will be the European provider of VitalQC to 10 European countries: Germany, Netherlands, Belgium, Switzerland, Norway, Spain, Italy, France, UK and Ireland.
“Aerocom pneumatic tube systems have been designed to reduce the impact on blood sample transport. Quality assurance for blood transportation in pneumatic tube systems is quickly becoming a requirement for our customers to satisfy regulatory requirements. With the Motryx agreement, Aerocom raises the bar in providing quality assurance. This agreement enables Aerocom to offer an even better and more complete solution to laboratories and hospitals around the world,” said Roland Pfitzer, CEO at Aerocom.
“Since Motryx’s inception, we have focused on developing a new standard for quality control for Pneumatic Tube Systems – one that is simple, repeatable, and robust. VitalQC provides a framework to check existing installations, or to facilitate the transition to occupancy for new builds. Our agreement with Aerocom provides assurance to their customers in markets with a strong focus on quality control, such as Germany and Scandinavia. With VitalQC, all hospital stakeholders can trust that their PTS will deliver blood products and clinical samples safely to their destination and will fulfill accreditation requirements. With over 2000 installations in hospitals worldwide, Aerocom is an ideal partner to bring VitalQC to market,” said Dr Franziska Broell, CEO at Motryx.
The agreement is effective immediately and allows for pneumatic systems to be validated and verified with little to no blood, streamlining and simplifying the process for all hospital stakeholders, including the lab.
About Motryx
Established in 2018, Motryx has developed an end-to-end solution for quality control and assurance for blood sample transport. VitalQC was specifically designed as a system process diagnostic tool for blood sample transport systems such as pneumatic tube systems. Motryx is headquartered in Halifax, Canada. VitalQC has been used by hospitals, laboratories and leading research institutes worldwide to confirm safe transport before installing new transport systems, to alert of changes in system performance, and to optimize transport processes, all to increase efficiency, effectiveness, and the quality of patient results.
About Aerocom
Aerocom is a global market leader in high-tech pneumatic transport systems and was founded in 1956.
Aerocom has focused exclusively on pneumatic tube systems in healthcare worldwide for almost 70 years. Their products are represented in more than 80 countries around the globe and are supported by their own branches and local partners. Aerocom offers the highest quality and best service.
For more information
www.motryx.com
www.aerocom.de
Dr Franziska Broell
CEO, Motryx Inc
[email protected]
Mar 2, 2020 | IR-Scientific, Motryx, News
See original ACOA news release here
Atlantic Canada’s life sciences companies reaching global markets
Businesses are commercializing products to improve lives and transform Atlantic Canada’s economy
March 2, 2020 – Halifax, Nova Scotia – Atlantic Canada Opportunities Agency
Atlantic Canada’s growing life sciences industry is moving the economy toward a more prosperous future. Today, four Halifax-area companies are one step closer to bringing their innovative healthcare solutions for a wide range of challenges to the world:
- Motryx has found a way to protect and monitor blood samples moving between hospitals and laboratories;
- Nxtgen Care is combating loneliness, a condition known to have negative health effects, especially for seniors;
- IR Scientific’s solution relieves pain in sensitive teeth; and,
- Skinfix specializes in clean and clinically active skincare to improve skin health.
Growing life sciences sector
These companies are part of a cluster of more than one hundred locally-owned life sciences businesses that are growing revenues and attracting new investments across the region. The life sciences sector is an important contributor to the economy, providing thousands of good jobs for Atlantic Canadians. The sector is gaining momentum in the region and is building an international reputation for success. Atlantic Canada has made Startup Genome’s list of ecosystems to watch in the life sciences category in its 2019 Global Startup Ecosystem Report.
Investments for growth and expansion
René Arseneault, Parliamentary Secretary to the Minister of Economic Development and Official Languages, and Andy Fillmore, Parliamentary Secretary to the Minister of Infrastructure and Communities and Member of Parliament for Halifax, announced contributions totaling $1,746,850 to help four life sciences companies commercialize their healthcare solutions, benefiting the local economy. This announcement was made on behalf of the Honourable Mélanie Joly, Minister of Economic Development and Official Languages.
The Government of Canada will continue to invest in small- and medium-sized businesses to help them scale up, increase productivity and participate in the global economy. Support for these projects is one way the Government of Canada is working to achieve its Atlantic Growth Strategy outcome of long-term economic prosperity in the region.
Quotes
“Strong regional economies are essential to grow a successful and sustainable Canadian economy. The Atlantic Canada Opportunities Agency is there to help businesses and innovators grow, succeed and create good jobs for Atlantic Canadians. Our government is making strategic investments that will enable businesses in all regions of the country gain a competitive edge.”
- The Honourable Mélanie Joly, Minister of Economic Development and Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency
“Halifax’s life sciences cluster is at the heart of a vibrant and growing Atlantic innovation ecosystem that has the talent and resources to compete on a global scale. The economic potential of this sector is incredible and we can be rightfully proud of its achievements to date. With its continued growth, I believe we are well-positioned to move our economy into a prosperous future.”
- Andy Fillmore, Parliamentary Secretary to the Minister of Infrastructure and Communities and Member of Parliament for Halifax
“This project will move the marker closer toward commercializing the Motryx product for blood transportation in hospitals as well as in private laboratories. This funding will allow us to hire strategic technical expertise as well as grow our sales force to reach customers in these markets, which have a combined addressable value of over $800 million.”
– Dr. Franziska Broell, CEO and Founder, Motryx Inc.
“Nxtgen CareTM is leading a Revolution in Seniors Care. Our business intelligence and analytics platform creates a real-time community of care for senior living facilities – optimizing care delivery while enhancing resident care levels. This project will allow us to grow our local team, invest in our flagship Care ScorecardTM and resident M-FactorTM digital health products and execute agreements in place within the coveted US healthcare marketplace.”
– Dan LeBlanc, President, Nxtgen Care
“This funding allows IR Scientific to continue its primary market research, expand oral care product claims beyond sensitivity and secure a global supply for our partners. With the help of four new employees, external resources, continued investor support and this funding program, IR Scientific is able to create incredible value, for our partners, our investors, and Atlantic Canada.”
- Andrew Doyle, CEO IR Scientific Inc.
“This funding will allow Skinfix to effectively compete in the $150 billion global skincare market as the first clean, clinically validated skincare brand. Skinfix will use the funds to hire expert industry talent and build marketing programs to propel the brand at Sephora in North America, where skincare has now become the largest beauty category for the first time in Sephora’s history. This project will help Skinfix drive awareness for its highly unique proposition as the first scientifically validated, wellness focused skincare brand.”
- Amy Risely, Founder & CEO, Skinfix
Quick Facts
- The Government of Canada is providing repayable contributions through the Atlantic Canada Opportunities Agency’s Regional Economic Growth through Innovation (REGI) program.
- The Business Scale-up and Productivity stream of the REGI program supports businesses at various stages of development, including high-growth firms, to accelerate their growth, help them scale-up and improve their productivity and competitiveness in both domestic and global markets.
Related products
- Backgrounder: Atlantic Canada’s life sciences companies reaching global markets
Associated Links
– 30 –
Contacts
Alexander Cohen
Press Secretary
Office of the Minister of Economic
Development and Official Languages
[email protected]
Chris Brooks Director, Communications and Outreach Atlantic Canada Opportunities Agency
902-426-9417 / 902-830-3839 (cell)
[email protected]
Dr. Franziska Broell
CEO, Motryx
902-448-4152
[email protected]
Dan LeBlanc
President, Nxtgen Care
902-802-1058
[email protected]
Roar Askheim
Chief Financial Officer, IR Scientific
902-448-4401
[email protected]
Katheryn Spears
Marketing Manager, SkinFix
902-789-0949
[email protected]
Stay connected
Follow the Atlantic Canada Opportunities Agency on social media: Twitter and LinkedIn
Backgrounder: Atlantic Canada’s life sciences companies reaching global markets
Businesses are commercializing products to improve lives and transform Atlantic Canada’s economy
March 2, 2020 – Halifax, Nova Scotia – Atlantic Canada Opportunities Agency
Today, René Arseneault, Parliamentary Secretary to the Minister of Economic Development and Official Languages, and Andy Fillmore, Parliamentary Secretary to the Minister of Infrastructure and Communities and Member of Parliament for Halifax, announced contributions totaling $1,746,850 to help four life sciences companies commercialize their healthcare solutions, benefiting the local economy. The announcement was made on behalf of the Honourable Mélanie Joly, Minister of Economic Development and Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency (ACOA).
The Government of Canada is providing repayable contributions through ACOA’s Regional Economic Development through Innovation (REGI) program to the following four companies:
Motryx Inc. – Halifax, NS
$500,000
Motryx Inc. has developed a hardware and software solution, called the VitalVial and VitalReport, for hospitals and laboratories to monitor blood sample transport from patient to the reference laboratory. The VitalVial is a diagnostic quality control sample that measures indicators – such as the vibration, temperature and pressure of the blood – known to effect the accuracy of blood tests. Used in combination with the VitalReport, this solution provides a new quality assurance method to the blood vial transportation industry.
The project will enable Motryx to undertake research, development and scale-up activities, including pilot projects with private labs to help it fully commercialize its technology. The company will also work to create a sales funnel. This project will create seven full-time positions.
Nxtgen Care (Checkin Innovative Care Technologies Inc.) – Dartmouth, NS
$500,000
Nxtgen Care is a start-up developing an integrated solution to help caregivers, businesses, residents and their families live socially active and connected lives. The system uses non-intrusive beacons and a wearable bracelet to measure the frequency, type, duration, proximity and factors in key personality traits to determine meaningfulness (referred to as the “M-Factor”) of social interactions. Understanding a resident’s M-Factor will equip senior care facilities with the tools needed to address loneliness, a leading problem in geriatric patients.
The project includes purchasing real-time-location-system sensors to enable senior care providers to better utilize their time and facility managers to better utilize their staff. Implementing this system will ultimately make care providers more accountable to their clients and family members while encouraging more meaningful interactions to combat the negative effects of loneliness.
IR Scientific – Halifax, NS
$496,850
IR Scientific’s novel oral care product, Sensi-IP, can be added to any toothpaste or mouthwash to treat sensitive teeth. Sensi-IP helps to close the exposed dentinal tubules that cause sensitive teeth, putting a stop to pain while strengthening the teeth.
The company will purchase equipment to support in-house toothpaste manufacturing for testing purposes, hire research & development staff as well as a commercialization manager. IR Scientific will also engage consultants to conduct market research and analysis to find new opportunities. Overall, the project will help the company expand the applications for its proprietary solution, Sensi-IP.
SkinFix – Halifax, NS
$250,000
SkinFix Inc. specializes in all-natural healing balms and skin care. Its heritage products are centuries old, and are made with wound-healing botanicals and emollient protective oils that have the ability to treat and manage the most severe dermatitis conditions.
The company is undertaking marketing activities including sample distributions, website development, as well as product showcasing at dermatology conferences, seminars and Sephora events. This project will help the company expand throughout the United States in all Sephora cosmetic stores and create six full-time positions.
Nov 6, 2019 | MNP, Motryx, News
FOR IMMEDIATE RELEASE
November 6, 2019
BioNova Announces Motryx as the Winner of the Ninth Annual BioInnovation Challenge (BIC) at BioPort 2019
Halifax, NS – November 6, 2019 – Today Motryx from Nova Scotia was named the winner of BioNova’s ninth annual BioInnovation Challenge (BIC) business pitch competition at BioPort 2019. Motryx is developing high-resolution, wireless, water and temperature resistant data-loggers with data analysis capabilities.
“The BioInnovation Challenge has positioned us for fast acceleration,” Franziska Broell, of Motryx said, “We have benefitted not only from winning, but from the program and training it provided as a whole.”
Atlantic Canada’s best health and life science innovators participate in the BioInnovation Challenge (BIC) business pitch competition each year. The competition’s goal is to help ease the transition from research laboratory to market. Motryx will receive a prize package that includes $25,000 in seed funding and an advisory services package worth more than $30,000. Motryx was up against SeeChange Biochemistry and Fieldetect.
“Selecting a winner was difficult for our judges panel as all three finalists have what it takes to make their start up a success,” said Scott Moffitt, Executive Director of BioNova. “Congratulations to Motryx.”
The Judging Panel:
Jennifer Hamilton, PhD – Senior Director, New Ventures at Johnson & Johnson Innovation and Advisor to Johnson & Johnson’s Impact Investing team
Arif Aziz, PhD – Senior Manager, National Life Science SR&ED, MNP
Milos Todorovic, PhD – International Business Development Officer, Global Affairs Canada
-30-
Media Contact:
Shana Cristoferi, Marketing Manager, BioNova
902-830-9193
[email protected]
About BioNova
BioNova leads, accelerates, and advocates for Nova Scotia’s growing health and life sciences sector. Since 1993, BioNova has been accelerating the growth of its member companies. By hosting networking and educational events, and providing connections to potential funders and business resources, BioNova helps companies succeed. While these companies commercialize life-changing research to improve healthcare, provide healthier food, and develop sustainable solutions, BioNova advocates on behalf of the sector. BioNova champions the sector’s cluster of world-class research facilities, incubator programs, and companies who, together, bring investment and jobs to Nova Scotia. www.bionova.ca